A new synthesis of carboxyterfenadine (fexofenadine) and its bioisosteric tetrazole analogs

Farmaco

Volumn 54, Issue 9, 1999, Pages 600-610

  Di Giacomo, Barbara ^a   Coletta, Donato ^a   Natalini, Benedetto ^a   Ni, Ming Hong ^a   Pellicciari, Roberto ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Antihistamine; Enantioselective reduction; Tetrazole

Indexed keywords

ANTIHISTAMINIC AGENT; FEXOFENADINE;

ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG SYNTHESIS; ENANTIOMER; NONHUMAN; STRUCTURE ACTIVITY RELATION;

HISTAMINE H1 ANTAGONISTS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; TERFENADINE;

EID: 0032826795     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00070-1     Document Type: Article

References (24)

1. For a review on Terfenadine, see: D. McTavish, K.L. Goa, M. Ferrill, Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy, Drugs 39 (1990) 552-574.
2. Woodward J.K., Munro N.L. Terfenadine, the first non-sedating antihistamine. Arzneim.-Forsch./Drug Res. 32:1982;1154-1156.
3. Monahan B.P., Ferguson C.L., Killeavy F.S., Lloyd B.K., Troy J., Cantilena L.R. Jr Torsades de pointes occurring in association with terfenadine use. J. Am. Med. Assoc. 264(21):1990;2788-2790.
4. Yun C., Okerholm R.A., Guengerich F.P. Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Drug Metab. Dispos. 21(3):1993;403-409.
5. Lesson G.A., Chan K.J., Knapp W.C., Biedenbach S.A., Wrigth G.J., Okerholm R.A. Metabolic disposition of terfenadine in laboratory animals. Arzneim.-Forsch./Drug Res. 32:1982;1173-1178.
6. Garteiz D.A., Hook R.H., Walker B.J., Okerholm R.A. Pharmacokinetics and biotransformation studies of terfenadine in man. Arzneim.-Forsch./Drug Res. 32:1982;1185-1190.
7. Chen T.-M., Chan K.Y., Coutant J.E., Okerholm R.A. Determination of the metabolites of terfenadine in human urine by thermospray liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 9:1991;929-933.
8. Unpublished data from Merrel Dow Pharmaceuticals.
9. Woodward J.K. Pharmacology of nonsedating antihistamines. New Perspectives on Antihistamines. 1989;Oxford Clinical Communications, Oxford.
10. Simons K.J., Martin T.J., Watson W.T.A., Simons F.E.R. Pharmacokinetics and pharmacodynamics of terfenadine and chlorpheniramine in the elderly. J. Allergy Clin. Immunol. 85:1990;540-547.
11. Honig P.K., Woosley R.L., Zamani K., Conner D.P., Cantilena L.R. Changes in pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin. Pharmacol. Ther. 52:1992;231-238.
12. Eller M.G., Okerholm R.A. Pharmacokinetic interaction between terfenadine and ketoconazole. Clin. Pharmacol. Ther. 49:1991;130.
13. Zimmerman M., Duruz H., Broccard O., Levy D., Lacatis D., Bloch A. Torsades de pointes after treatment with terfenadine and ketoconazole. Eur. Heart J. 13:1992;1002-1003.
14. Pohjola-Sintonen S., Viitasalo M., Toivonen L., Neuvonen P. Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia. Eur. J. Clin. Pharmacol. 45:1993;191-193.
15. Kawai S.H., Hambalek R.J., Just G. A facile synthesis of an oxidation product of terfenadine. J. Org. Chem. 59:1994;2620-2622.
16. Patel S., Waykole L., Repic O., Chen K.-M. Synthesis of terfenadine carboxylate. Synth. Commun. 26(24):1996;4699-4710.
17. Fang Q.K., Senanayake C.H., Scott Wilkinson H., Wald S.A., Li H. An efficient and facile synthesis of racemic and optically active fexofenadine. Tetrahedron Lett. 39:1998;2701-2704.
18. C. Giordano, G. Castaldi, F. Uggeri, F. Gurzoni, Synthesis of 2-arylalkanoic acids: zinc bromide-assisted methanolysis of α-bromoalkyl aryl ketones, Synthesis (1985) 436-437.
19. Carr A.A., Meyer D.R. Synthesis of terfenadine. Arzneim.-Forsch./Drug Res. 32:1982;1157-1159.
20. Brown H.C., Chandrasekharan J., Ramachandran P.V. Chiral synthesis via organoboranes. 14. Selective reductions. 41. Diisopino-campheylchloroborane, an exceptionally efficient chiral reducing agent. J. Am. Chem. Soc. 110:1988;1539-1546.
21. Wallace R.M., Young J.M. Temperature dependence of the binding of 3H-mepyramine and related compounds to the histamine H1-receptor. Mol. Pharmacol. 23:1983;60-66.
22. Chang R.S.L., Tran V.T., Snyder S.H. Histamine H1-receptors in brain labeled with 3H-mepyramine. Eur. J. Pharmacol. 48:1978;463-464.
23. Hill S.J., Young J.M., Marrian D.H. Specific binding of 3H-mepyramine to histamine H1-receptors in intestinal smooth muscle. Nature. 270:1977;361-363.
24. Surapaneni S., Khalil S.K.W. A preliminary pharmacokinetic study of the enantiomers of the terfenadine acid metabolite in humans. Chirality. 6:1994;479-483.